MRNA insider trading — Moderna, Inc.
No open-market insider purchases or sales were filed for Moderna, Inc. (MRNA) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.
Updated Oct 16, 2026.
Recent MRNA insider transactions
Every Form 4 filed by Moderna, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Mock James M | Chief Financial Officer | M · Option exercise | Direct | 1,454 | — | — | Form 4 |
| Oct 5, 2026 | Mock James M | Chief Financial Officer | F · Tax withholding | Direct | 704 | $190.01 | $134K | Form 4 |
| Sep 15, 2026 | Hoge Stephen | President | M · Option exercise · 10b5-1 | Direct | 76,452 | $12.21 | $933K | Form 4 |
| Sep 15, 2026 | Hoge Stephen | President | S · Sale · 10b5-1 | Direct | 40,281 | $146.07 | $5.88M | Form 4 |
| Sep 14, 2026 | Hoge Stephen | President | M · Option exercise · 10b5-1 | Direct | 76,453 | $12.21 | $933K | Form 4 |
| Sep 14, 2026 | Hoge Stephen | President | S · Sale · 10b5-1 | Direct | 40,294 | $144.13 | $5.81M | Form 4 |
| Sep 10, 2026 | Mock James M | Chief Financial Officer | M · Option exercise · 10b5-1 | Direct | 19,836 | $30.96 | $614K | Form 4 |
| Sep 10, 2026 | Mock James M | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 34,836 | $134.49 | $4.69M | Form 4 |
| Sep 4, 2026 | Mock James M | Chief Financial Officer | M · Option exercise | Direct | 11,797 | — | — | Form 4 |
| Sep 4, 2026 | Mock James M | Chief Financial Officer | F · Tax withholding | Direct | 5,704 | $148.87 | $849K | Form 4 |
| Sep 4, 2026 | Klinger Shannon Thyme | Chief Legal Officer | M · Option exercise | Direct | 11,797 | — | — | Form 4 |
| Sep 4, 2026 | Klinger Shannon Thyme | Chief Legal Officer | F · Tax withholding | Direct | 5,704 | $148.87 | $849K | Form 4 |
| Sep 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | M · Option exercise · 10b5-1 | Direct | 5,637 | $30.96 | $107K | Form 4 |
| Sep 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | S · Sale · 10b5-1 | Direct | 3,471 | $139.95 | $486K | Form 4 |
| Sep 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | F · Tax withholding · 10b5-1 | Direct | 1,048 | $140.34 | $147K | Form 4 |
| Sep 1, 2026 | Mock James M | Chief Financial Officer | M · Option exercise | Direct | 2,475 | — | — | Form 4 |
| Sep 1, 2026 | Mock James M | Chief Financial Officer | F · Tax withholding | Direct | 1,197 | $140.34 | $168K | Form 4 |
| Sep 1, 2026 | Hoge Stephen | President | M · Option exercise | Direct | 9,283 | — | — | Form 4 |
| Sep 1, 2026 | Hoge Stephen | President | F · Tax withholding | Direct | 4,489 | $140.34 | $630K | Form 4 |
| Aug 28, 2026 | Hoge Stephen | President | M · Option exercise | Direct | 611 | — | — | Form 4 |
| Aug 28, 2026 | Hoge Stephen | President | F · Tax withholding | Direct | 296 | $142.77 | $42K | Form 4 |
| Aug 27, 2026 | Hoge Stephen | President | M · Option exercise | Direct | 1,437 | — | — | Form 4 |
| Aug 27, 2026 | Hoge Stephen | President | F · Tax withholding | Direct | 695 | $149.66 | $104K | Form 4 |
| Aug 28, 2026 | Klinger Shannon Thyme | Chief Legal Officer | M · Option exercise | Direct | 329 | — | — | Form 4 |
| Aug 28, 2026 | Klinger Shannon Thyme | Chief Legal Officer | F · Tax withholding | Direct | 160 | $142.77 | $23K | Form 4 |
| Aug 27, 2026 | Klinger Shannon Thyme | Chief Legal Officer | M · Option exercise | Direct | 774 | — | — | Form 4 |
| Aug 27, 2026 | Klinger Shannon Thyme | Chief Legal Officer | F · Tax withholding | Direct | 375 | $149.66 | $56K | Form 4 |
| Aug 28, 2026 | Mock James M | Chief Financial Officer | M · Option exercise | Direct | 329 | — | — | Form 4 |
| Aug 28, 2026 | Mock James M | Chief Financial Officer | F · Tax withholding | Direct | 160 | $142.77 | $23K | Form 4 |
| Aug 27, 2026 | Mock James M | Chief Financial Officer | M · Option exercise | Direct | 774 | — | — | Form 4 |
| Aug 27, 2026 | Mock James M | Chief Financial Officer | F · Tax withholding | Direct | 375 | $149.66 | $56K | Form 4 |
| Aug 6, 2026 | Bancel Stephane | Chief Executive Officer | M · Option exercise · 10b5-1 | Direct | 252,469 | $19.15 | $4.83M | Form 4 |
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer | M · Option exercise · 10b5-1 | Direct | 499,246 | $19.15 | $9.56M | Form 4 |
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer | S · Sale · 10b5-1 | Direct | 499,246 | $57.52 | $28.72M | Form 4 |
MRNA insider trading FAQ
Are insiders buying MRNA stock?
Not on the open market. In the last 90 days, Moderna, Inc. insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading MRNA?
No insider bought or sold on the open market in the last 90 days.
Where does MRNA insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.